Evaluation of the Agreement Between a New Pyramid Wavefront Sensor Aberrometer and Scheiner-Smirnov Aberrometers.

PURPOSE: To assess agreement between a new aberrometer (Osiris-T; CSO) employing pyramid wavefront sensor technique and Scheiner-Smirnov aberrometer (OPD-Scan III; Nidek) on measuring ocular, corneal, and internal aberrations in healthy participants. METHODS: The measurements were conducted three times consecutively by an experienced examiner. The total root mean square (RMS) aberrations, higher order aberration RMS, coma Z3±1, trefoil Z3±3, spherical aberration Z40, and astigmatism II Z4±2 up to 7th order were exported in both 4-and 6-mm pupil zones. The parameters between the two devices were statistically compared using the paired t-test, and the differences assessed with Bland-Altman plots and 95% limits of agreement. RESULTS: This prospective study included 70 right eyes of 70 healthy participants with an average age of 25.94 ± 6.59 years (range: 18 to 47 years). The mean difference in the two devices ranged from 0.01 µm for astigmatism II Z4±2 to 0.63 µm for total RMS in 4 mm and from 0.01 to 1.41 µm in 6-mm pupil size. The Bland-Altman analysis of ocular, corneal, and internal aberrations indicated high agreement between the two devices and the maximum absolute values for 95% limits of agreement ranged from 0.03 to 1.06 µm for 4-mm pupil diameters and 0.12 to 1.13 µm for 6-mm pupil diameters. CONCLUSIONS: The newly developed pyramid wavefront sensor technique aberrometer demonstrated a high agreement with a Scheiner-Smirnov aberrometer when measuring ocular, corneal, and internal aberrations in healthy participants. Thus, the two aberrometers may be considered interchangeable for clinical applications. [J Refract Surg. 2024;40(4):e218-e228.].

Precision of Corneal Aberrations Measured by a New SD-OCT/Placido Topographer and Its Agreement With a Scheimpflug/Placido Topographer.

PURPOSE: To evaluate the precision of corneal aberrations measured by a new SD-OCT/Placido topographer, the MS-39 (CSO), and to compare them with those provided by a Scheimpflug/Placido device, the Sirius (CSO), in normal eyes. METHODS: This study enrolled 90 normal eyes of 90 patients. Total root mean square (RMS), higher order RMS, coma, trefoil, spherical aberration, and astigmatism II were analyzed. The within-subject standard deviation (Sw), test-retest repeatability, and intraclass correlation coefficient (ICC) were calculated to assess the precision. Bland-Altman plots and 95% limits of agreement (LoAs) were calculated to assess the agreement. RESULTS: For intraobserver repeatability of anterior and total corneal aberrations, most of the ICCs were greater than 0.869, except for trefoil and astigmatism II. Regarding the posterior corneal surface, the ICCs of total RMS, coma, and spherical aberration were higher than 0.878, whereas the ICCs of higher order RMS, trefoil, and astigmatism II were lower than 0.626. All test-retest repeatability values were 0.17 µm or less. In terms of interobserver reproducibility, the Sw values were 0.04 µm or less, Test-retest repeatability values were less than 0.11 µm, and all ICCs ranged from 0.532 to 0.996. Regarding agreement, 95% LoAs were small for all Zernike coefficients, and the mean difference was close to zero. CONCLUSIONS: The new SD-OCT/Placido device exhibited excellent repeatability and reproducibility for anterior and total surface, whereas total RMS, coma, and spherical aberrations showed high precision on the posterior surface. High agreement was confirmed between the SD-OCT/Placido and Scheimpflug/Placido devices. [J Refract Surg. 2023;39(6):405-412.].

Corneal Higher-Order Aberrations Measurements: Precision of SD-OCT/Placido Topography and Comparison with a Scheimpflug/Placido Topography in Eyes After Small-Incision Lenticule Extraction.

INTRODUCTION: The aim of this study was to evaluate the measurements of corneal higher-order aberrations (HOAs) obtained by a new anterior segment optical coherence tomography (OCT) technique combined with a Placido topographer (the MS-39 device) in eyes with prior small-incision lenticule extraction (SMILE) and compare them to the measurements obtained by a Scheimpflug camera combined with a Placido topographer (the Sirius device). METHODS: A total of 56 eyes (56 patients) were included in this prospective study. Corneal aberrations were analyzed for the anterior, posterior, and total cornea surfaces. Within-subject standard deviation (Sw), test-retest repeatability (TRT), and intraclass correlation coefficient (ICC) were used to assess the intraobserver repeatability and interobserver reproducibility. The differences were evaluated by paired t-test. Bland-Altman plots and 95% limits of agreement (95% LoA) were used to evaluate the agreement. RESULTS: High repeatability was observed for anterior and total corneal parameters, with Sw value < 0.07, TRT ≤ 0.16, and ICCs > 0.893, but not trefoil. For the posterior corneal parameters, ICCs varied from 0.088 to 0.966. Regarding interobserver reproducibility, all Sw values were ≤ 0.04 and TRT ≤ 0.11. ICCs ranged from 0.846 to 0.989, from 0.432 to 0.972, and from 0.798 to 0.985 for the anterior, total, and posterior corneal aberrations parameters, respectively. The mean difference in all aberrations was ≤ 0.05 µm. All parameters showed a narrow 95% LoA. CONCLUSION: The MS-39 device achieved high precision in both anterior and total corneal measurements; the precision of posterior corneal higher-order RMS, astigmatism II, coma, and trefoil was lower. The two technologies used by the MS-39 and Sirius devices can be used interchangeably for measuring corneal HOAs after SMILE.

Blocking Spatiotemporal Crosstalk between Subcellular Organelles for Enhancing Anticancer Therapy with Nanointercepters.

The spatiotemporal characterization of signaling crosstalk between subcellular organelles is crucial for the therapeutic effect of malignant tumors. Blocking interactive crosstalk in this fashion is significant but challenging. Herein, a communication interception strategy is reported, which blocks spatiotemporal crosstalk between subcellular organelles for cancer therapy with underlying molecular mechanisms. Briefly, amorphous-core@crystalline-shell Fe@Fe3 O4 nanoparticles (ACFeNPs) are fabricated to specifically block the crosstalk between lysosomes and endoplasmic reticulum (ER) by hydroxyl radicals generated along with their trajectory through heterogeneous Fenton reaction. ACFeNPs initially enter lysosomes and trigger autophagy, then continuous lysosomal damage blocks the generation of functional autolysosomes, which mediates ER-lysosome crosstalk, thus the autophagy is paralyzed. Thereafter, released ACFeNPs from lysosomes induce ER stress. Without the alleviation by autophagy, the ER-stress-associated apoptotic pathway is fully activated, resulting in a remarkable therapeutic effect. This strategy provides a wide venue for nanomedicine to exert biological advantages and confers new perspective for the design of novel anticancer drugs.